Dr. Salz’s research aims to improve the quality of care for cancer survivors, focusing primarily on late effects after cancer treatment. Her research addresses survivorship interventions, including needs assessments, clinical intervention development, and effectiveness testing. She currently leads an American Cancer Society-funded trial to test the implementation and effectiveness of a web-based intervention for personalizing the ongoing care of head and neck cancer survivors. Another area of her research addresses risk stratification of survivorship care through late effects modeling. Dr. Salz is developing models to predict the risk of cardiovascular late effects among lymphoma survivors to guide cardiovascular preventive care for this vulnerable population. She also is investigating trends in pain management among cancer survivors, focusing on trends in opioid use.